Zinc Therapy for Wilson Disease in Children in French Pediatric Centers

Journal of Pediatric Gastroenterology and Nutrition

Volumn 61, Issue 6, 2015, Pages 613-618

  Santiago, Raoul ^a   Gottrand, Frédéric ^b   Debray, Dominique ^c   Bridoux, Laure ^d   Lachaux, Alain ^e   Morali, Alain ^f   Lapeyre, Delphine ^a   Lamireau, Thierry ^a  

^a University Hospital   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e University Hospital   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

adverse effects; chelators; child; Wilson disease; zinc

Indexed keywords

AMINOTRANSFERASE; PENICILLAMINE; TRIENTINE; ZINC ACETATE; CHELATING AGENT; COPPER; TRACE ELEMENT; ZINC;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHELATION THERAPY; CHILD; CYTOLYSIS; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; FRANCE; HUMAN; LEUKOPENIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; PEDIATRIC HOSPITAL; PERITONITIS; PRIORITY JOURNAL; STOMACH PERFORATION; VOMITING; WILSON DISEASE; ABDOMINAL PAIN; ADOLESCENT; BLOOD; COMPLICATION; DRUG EFFECTS; HEALTH CARE FACILITY; HEALTH CARE SURVEY; HEPATOLENTICULAR DEGENERATION; INFANT; LIVER; METABOLISM; PATHOLOGY; PEDIATRICS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STOMACH; TREATMENT OUTCOME;

ABDOMINAL PAIN; ADOLESCENT; CHELATING AGENTS; CHILD; CHILD, PRESCHOOL; COPPER; FEMALE; FRANCE; HEALTH CARE SURVEYS; HEALTH FACILITIES; HEPATOLENTICULAR DEGENERATION; HUMANS; INFANT; LIVER; MALE; PEDIATRICS; PENICILLAMINE; RETROSPECTIVE STUDIES; STOMACH; TRACE ELEMENTS; TRANSAMINASES; TREATMENT OUTCOME; TRIENTINE; ZINC; ZINC ACETATE;

EID: 84957711934     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000926     Document Type: Article

References (30)

1. Ala A, Walker AP, Ashkan K, et al. Wilson's disease. Lancet 2007;369: 397-408.
2. Trocello JM, Chappuis P, Chaine P, et al. Wilson disease. Presse Med 2009;38:1089-98.
3. Tao TY, Gitlin JD. Hepatic copper metabolism: insights from genetic disease. Hepatology 2003;37:1241-7.
4. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008;47:2089-111.
5. Haute Autorité de Santé. Commission de la Transparence. http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032326.pdf. Published November 2, 2005. Accessed January 5, 2015.
6. Hoogenraad TU. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 2006;28:141-6.
7. European Association for Study of Liver. EASL clinical practice guidelines: Wilson's disease. J Hepatol 2012;56:671-85.
8. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-93.
9. Nicastro E, Ranucci G, Vajro P, et al. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 2010;52:1948-56.
10. Rodriguez B, Burguera J, Berenguer M. Response to different therapeutic approaches inWilson disease. A long-term follow up study. Ann Hepatol 2012;11:907-14.
11. Abdel Ghaffar TY, Elsayed SM, Elnaghy S, et al. Phenotypic and genetic characterization of a cohort of pediatricWilson disease patients. BMC Pediatr 2011;11:56.
12. Shimizu N, Fujiwara J, Ohnishi S, et al. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism. Transl Res 2010;156:350-7.
13. Wiggelinkhuizen M, Tilanus ME, Bollen CW, et al. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009;29: 947-58.
14. Linn FH, Houwen RH, van Hattum J, et al. Long-term exclusive zinc monotherapy in symptomaticWilson disease: experience in 17 patients. Hepatology 2009;50:1442-52.
15. Czlonkowska A, Gajda J, Rodo M. Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. J Neurol 1996;243:269-73.
16. Alexiou D, Hatzis T, Koutselinis A. Maintenance treatment of Wilson's disease with oral zinc. A propos of a child treated for 4 years. Arch Fr Pediatr 1985;42:447-9.
17. Milanino R, Deganello A, Marrella M, et al. Oral zinc as initial therapy in Wilson's disease: two years of continuous treatment in a 10-year-old child. Acta Paediatr 1992;81:163-6.
18. Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years. J Lab Clin Med 2001;137:191-8.
19. Marcellini M, Di Ciommo V, Callea F, et al. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med 2005; 145:139-43.
20. Ranucci G, Di Dato F, Spagnuolo MI, et al. Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study. Orphanet J Rare Dis 2014;9:41-51.
21. Mishra D, Kalra V, Seth R. Failure of prophylactic zinc in Wilson disease. Indian Pediatr 2008;45:151-3.
22. Weiss KH, Gotthardt DN, Klemm D, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 2011;140:1189-98.
23. Walshe JM, Munro NA. Zinc-induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet. Arch Neurol 1995;52:10-1.
24. Haute Autorité de Santé. Maladie de Wilson, Protocole National de Diagnostic et de Soins 2008. http://www.has-sante.fr/portail/upload/docs/application/pdf/pnds-wilson-web-revu-afssaps.pdf. Accessed January 5, 2015.
25. Merle U, Schaefer M, Ferenci P, et al. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007;56:115-20.
26. Wiernicka A, Janczyk W, Dadalski M, et al. Gastrointestinal side effects in children with Wilson's disease treated with zinc sulphate. World J Gastroenterol 2013;19:4356-62.
27. Mizuochi T, Kimura A, Shimizu N, et al. Zinc monotherapy from time of diagnosis for young pediatric patients with presymptomatic Wilson disease. J Pediatr Gastroenterol Nutr 2011;53:365-7.
28. Iorio R1, D'Ambrosi M, Marcellini M, et al., Hepatology Committee of Italian Society of Paediatric Gastroenterology Hepatology and Nutrition. Serum transaminases in children with Wilson's disease. J Pediatr Gastroenterol Nutr 2004;39:331-6.
29. Rodríguez BI, Burguera J, Berenguer M. Response to different therapeutic approaches inWilson disease. A long-term follow up study. Ann Hepatol 2012;11:907-14.
30. Pecoud A, Dozel F, Schelling JL. The effects of foodstuffs on the absorption of zinc sulphate. Clin Pharmacol Ther 1975;17:469-74